Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2022

View Archived Issues

CD14 associated with poor cognitive function in survivors of testicular germ-cell tumors

Lipidated IL-22 ameliorates colon inflammation in preclinical colitis model

Study shows how gut-derived metabolites enter the brain and affect behavior

IBD-3540, a novel gut-restricted GCPII inhibitor with oral preclinical activity in models of colitis

Shaanxi Synthetic Pharmaceutical divulges new antiarthritic drugs

Guangzhou Henovcom Bioscience discloses new antivirals

T2YC presents new integrin modulators

IFM Due synthesizes new hSTING antagonists

Institute of Medicinal Biotechnology presents new androgen receptor antagonists

Targeting of CRYAB with 25-hydroxycholesterol induces kills senescent cells in vitro and in vivo

AU-011 shows promising binding and tumor distribution in models of urothelial neoplasia

DNA methylation mediated by METTL3-METTL14 complex is largely restricted by structured RNA elements

CD70 identified as promising therapeutic target in advanced RCC

Moderna announces new mRNA vaccine candidates for HSV, VZV and cancer

SIGMAR1 targeting ameliorates preclinical Wolfram syndrome symptoms

GR-3027 reverses neuroinflammation in rat model of hyperammonemia

"Twin study" of sorts brings insight into arthritis microbiome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...